The Enterprise Value as of June 2026 (TTM) for Ensysce Biosciences, Inc. (ENSC) is 1.83M

According to Ensysce Biosciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.83M. This represents a change of -100.00% compared to the average of -1000907952325.89 of the last 4 quarters.

Ensysce Biosciences, Inc. (ENSC) Historical Enterprise Value (quarterly & annually)

How has ENSC Enterprise Value performed in the past?

The mean historical Enterprise Value of Ensysce Biosciences, Inc. over the last ten years is 128.26B. The current 1.83M Enterprise Value has changed -99.86% with respect to the historical average. Over the past ten years (40 quarters), ENSC's Enterprise Value was at its highest in in the June 2020 quarter at 278.44B. The Enterprise Value was at its lowest in in the December 2025 quarter at -4003643647560.00.

Ensysce Biosciences, Inc. (ENSC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Ensysce Biosciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Ensysce Biosciences, Inc. (ENSC) Average Enterprise Value

How has ENSC Enterprise Value performed in the past?

The current Enterprise Value of Ensysce Biosciences, Inc. (ENSC) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Ensysce Biosciences, Inc. (ENSC) Enterprise Value vs. Peers

How is ENSC’s Enterprise Value compared to its peers?

Ensysce Biosciences, Inc.’s Enterprise Value is greater than Soligenix, Inc. (-1266892.00), greater than Titan Pharmaceuticals, Inc. (-66329351.00), greater than Oragenics, Inc. (-3242702.00), less than KALA BIO, Inc. (55.91M), greater than Xenetic Biosciences, Inc. (-1303306.00), greater than AIM ImmunoTech Inc. (139.50K), greater than VYNE Therapeutics Inc. (-13823812.00), greater than Qualigen Therapeutics, Inc. (971.81K), greater than Kazia Therapeutics Limited (-36601866.82), less than Can-Fite BioPharma Ltd. (7.40B),

Build a custom stock screener for Ensysce Biosciences, Inc. (ENSC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ensysce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Ensysce Biosciences, Inc. (ENSC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Ensysce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.